Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art
S Weber, A Zimmer, J Pardeike - European Journal of Pharmaceutics and …, 2014 - Elsevier
Drug delivery by inhalation is a noninvasive means of administration that has following
advantages for local treatment for airway diseases: reaching the epithelium directly …
advantages for local treatment for airway diseases: reaching the epithelium directly …
Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting
In last two decades, the lipid nanocarriers have been extensively investigated for their drug
targeting efficiency towards the critical areas of the human body like CNS, cardiac region …
targeting efficiency towards the critical areas of the human body like CNS, cardiac region …
Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake
The poor stability of solid lipid nanoparticles (SLN) under acidic condition resulted in large
aggregation in gastric environment, limiting their application as oral delivery systems. In this …
aggregation in gastric environment, limiting their application as oral delivery systems. In this …
[HTML][HTML] Recent progress of lipid nanoparticles-based lipophilic drug delivery: focus on surface modifications
Numerous drugs have emerged to treat various diseases, such as COVID-19, cancer, and
protect human health. Approximately 40% of them are lipophilic and are used for treating …
protect human health. Approximately 40% of them are lipophilic and are used for treating …
[HTML][HTML] Solid lipid nanoparticles: multitasking nano-carriers for cancer treatment
J German-Cortés, M Vilar-Hernández, D Rafael… - Pharmaceutics, 2023 - mdpi.com
Despite all the advances seen in recent years, the severe adverse effects and low specificity
of conventional chemotherapy are still challenging problems regarding cancer treatment …
of conventional chemotherapy are still challenging problems regarding cancer treatment …
[HTML][HTML] Overview of P-glycoprotein inhibitors: a rational outlook
KMR Srivalli, PK Lakshmi - Brazilian Journal of Pharmaceutical …, 2012 - SciELO Brasil
P-glycoprotein (P-gp), a transmembrane permeability glycoprotein, is a member of ATP
binding cassette (ABC) super family that functions specifically as a carrier mediated primary …
binding cassette (ABC) super family that functions specifically as a carrier mediated primary …
Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration
The remarkable increase in the prevalence of neurodegenerative diseases has become a
serious public health problem. Considering the lack of effective treatments to address these …
serious public health problem. Considering the lack of effective treatments to address these …
The influence of nanoparticulate drug delivery systems in drug therapy
The advancement in medical sciences and perturbing limitations of some conventional drug
delivery systems have triggered extensive research in nanomedicine, and there have been …
delivery systems have triggered extensive research in nanomedicine, and there have been …
Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation
Considerable research efforts have been directed towards understanding the enigma of P-
glycoprotein (P-gp) in drug development and delivery. P-gp is a multi-specific drug efflux …
glycoprotein (P-gp) in drug development and delivery. P-gp is a multi-specific drug efflux …
Respirable nanocarriers as a promising strategy for antitubercular drug delivery
Tuberculosis is considered a fatal respiratory infectious disease that represents a global
threat, which must be faced. Despite the availability of oral conventional anti-tuberculosis …
threat, which must be faced. Despite the availability of oral conventional anti-tuberculosis …